Advertisement

Journal of Neurology

, Volume 261, Issue 9, pp 1811–1817 | Cite as

First symptom and initial diagnosis in sporadic CJD patients in Germany

  • Anna Krasnianski
  • Judith Kaune
  • Klaus Jung
  • Hans A. Kretzschmar
  • Inga Zerr
Original Communication

Abstract

To describe the first symptom/sign and first diagnosis in patients with sporadic Creutzfeldt-Jakob disease (sCJD) in Germany with respect to M129V polymorphism of the prion protein gene and prion protein type. Data on the first symptom/sign and first diagnosis were studied in 492 sCJD patients with probable and definite sCJD and known M129V polymorphism. Unspecific prodromal symptoms such as headache, fatigue, sleep disturbances, “peculiar feeling in the head”, photophobia or weight loss were found in about 10 % of the patients. No prodromal symptoms were found in MV2 and VV1 patients. Dementia was the most common first symptom (37 %) followed by cerebellar (34 %), visual (15 %), and psychiatric disturbances (14 %). The CJD diagnosis was the first diagnosis in only 35 % of the patients (in 42 % of MM, 28 % of MV, and 24.5 % of VV patients). We provide a detailed analysis on clinical presentation and first diagnosis in a large group of patients with sCJD with respect to M129V genotype and prion protein type. These data emphasize the importance of knowledge about CJD and especially rare CJD types among physicians of different specializations. Our findings may improve early recognition of atypical CJD forms.

Keywords

Prion disease Sporadic CJD M129V polymorphism First symptom 

Notes

Acknowledgments

First of all, we thank the patients and their families. The authors thank all physicians throughout Germany for providing clinical and neuropathological data on patients and for sending CSF and blood samples. We thank Mrs. Henn, Staniszewski, Bodemer, and Ciesielczyk for the excellent technical assistance. The assistance of Mrs. Ehrlich and Schneider-Dominco is gratefully acknowledged. This study was funded by the Robert Koch-Institute through funds of the Federal Ministry of Health (Grant number 1369-341) and the European Commission (PRIORITY, FP7-KBBE-2007-2A).

Conflicts of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical standard

All human studies were approved by the ethic commitee of the University of Göttingen. An Informed consent is availble in all patients.

References

  1. 1.
    Ali R, Baborie A, Larner AJ, White R (2013) Psychiatric presentation of sporadic Creutzfeldt–Jakob disease: a challenge to current diagnostic criteria. J Neuropsychiatry Clin Neurosci 25:335–338CrossRefPubMedGoogle Scholar
  2. 2.
    Brown P, Gibbs CJ Jr, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, Goldfarb LG, Gajdusek DC (1994) Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35:513–529CrossRefPubMedGoogle Scholar
  3. 3.
    Gao C, Shi Q, Tian C, Chen C, Han J, Zhou w, Zhang BY, Jiang HY, Zhang J, Dong XP (2011) The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt-Jakob disease patients in China: surveillance data from 2006 to 2010. PLoS One 6:e24231PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Heidenhain A (1929) Klinische und anatomische Untersuchungen über eine eigenartige organische Erkrankung des Zentralnervensystems im Praesenium. Z Ges Neurol Psychiatr 118:49–114CrossRefGoogle Scholar
  5. 5.
    Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, Steinhoff BJ, Grasbon-Frodl EM, Kretzschmar HA, Zerr I (2007) Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain 130:1350–1359CrossRefPubMedGoogle Scholar
  6. 6.
    Kitamoto T, Shin RW, Doh-Ura K, Tomokane N, Miyazono M, Muramoto T, Tateishi J (1992) Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt–Jakob disease. Am J Pathol 140:1285–1294PubMedCentralPubMedGoogle Scholar
  7. 7.
    Kovács GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, Van Duijn C, Collins S, Boyd A, Guilivi A, Coulthart M, Delasnerie-Laupretre N, Brandel JP, Zerr I, Kretzschmar H, de Pedro-Cuesta J, Calero-Lara M, Glatzel M, Aguzzi A, Bishop M, Knight R, Belay G, Will R, Mitrova E (2005) Genetic prion disease: the EUROCJD experience. Hum Genet 118:166–174CrossRefPubMedGoogle Scholar
  8. 8.
    Krasnianski A, Meissner B, Schulz-Schaeffer W, Kallenberg K, Bartl M, Heinemann U, Varges D, Kretzschmar H, Zerr I (2006) Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt–Jakob disease. Arch Neurol 63:876–880CrossRefPubMedGoogle Scholar
  9. 9.
    Krasnianski A, Schulz-Schaeffer WJ, Kallenberg K, Meissner B, Collie DA, Roeber S, Bartl M, Heinemann U, Varges D, Kretzschmar HA, Zerr I (2006) Clinical findings and diagnostic tests in the MV-2 subtype of sporadic CJD. Brain 129:2288–2296CrossRefPubMedGoogle Scholar
  10. 10.
    Kretzschmar HA, Ironside JW, DeArmond SJ, Tateishi J (1996) Diagnostic criteria for sporadic Creutzfeldt–Jakob disease. Arch Neurol 53:913–920CrossRefPubMedGoogle Scholar
  11. 11.
    Lampe J, Kitzler H, Walter MC, Lochmuller H, Reichmann H (1999) Methionine homozygosity at prion gene codon 129 may predispose to sporadic inclusion-body myositis [letter]. Lancet 353:465–466CrossRefPubMedGoogle Scholar
  12. 12.
    Meissner B, Westner I, Kallenberg K, Krasnianski A, Bartl M, Varges D, Boesenberg C, Kretzschmar HA, Knauth M, Schulz-Schaeffer WJ, Zerr I (2005) Sporadic Creutzfeldt–Jakob disease: clinical and diagnostic characteristics of the rare VV1 type. Neurology 65:1544–1550CrossRefPubMedGoogle Scholar
  13. 13.
    Palmer MS, Dryden AJ, Hughes JT, Collinge J (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease [published erratum appears in Nature 1991 Aug 8;352(6335):547] [see comments]. Nature 352:340–342CrossRefPubMedGoogle Scholar
  14. 14.
    Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar HA (1999) Classification of sporadic Creutzfeldt–Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224–233CrossRefPubMedGoogle Scholar
  15. 15.
    Rabinovici GD, Wang PN, Levin J, Cook L, Pravdin M, Davis J, DeArmond SJ, Barbaro NM, Martindale J, Miller BL, Geschwind M (2006) First symptom in sporadic Creutzfeldt–Jakob disease. Neurology 66:286–287CrossRefPubMedGoogle Scholar
  16. 16.
    Sass H, Wittchen HU, Zaudig M, Houben I (2003) Diagnostisches und Statistisches Manual Psychischer Störungen–Textversion-DSM-IV-TR. Hogrefe Verlag, GöttingenGoogle Scholar
  17. 17.
    Schulz-Schaeffer WJ, Tschoke S, Kranefuss N, Drose W, Hause-Reitner D, Giese A, Groschup MH, Kretzschmar HA (2000) The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol 156:51–56PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Stoeck K, Bodemer M, Ciesielczyk B, Meissner B, Bartl M, Heinemann U, Zerr I (2005) Interleukin 4 and interleukin 10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeldt–Jakob disease. Arch Neurol 62:1591–1594CrossRefPubMedGoogle Scholar
  19. 19.
    Wadsworth JD, Hill AF, Beck JA, Collinge J (2003) Molecular and clinical classification of human prion disease. Br Med Bull 66:241–254CrossRefPubMedGoogle Scholar
  20. 20.
    WHO (1998) Human transmissible spongiform encephalopathies. Wkly Epidemiol Rec 47:361–365Google Scholar
  21. 21.
    Will RG, Alpérovitch A, Poser S, Pocchiari M, Hofman A, Mitrova E, de Silva R, D’Alessandro M, Delasnerie-Lauprêtre N, Zerr I, van Duijn C (1998) Descriptive epidemiology of Creutzfeldt–Jakob disease in six European countries, 1993–1995. EU Collaborative Study Group for CJD. Ann Neurol 43:763–767CrossRefPubMedGoogle Scholar
  22. 22.
    Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie DA, Smith P, Varges D, Heinemann U, Meissner B, Roberts H, Brandel JP, Van Dujin CM, Pocchiari M, Begue P, Cras P, Will RG, Sanchez-Juan P (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt–Jakob disease. Brain 132:2659–2668PubMedCentralCrossRefPubMedGoogle Scholar
  23. 23.
    Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RSG, Bernheimer H, Cardone F, Delasnerie-Lauprêtre N, Cuadrado Corrales N, Ladogana A, Fletcher A, Bodemer M, Awan T, Ruiz Bremón A, Budka H, Laplanche JL, Will RG, Poser S (2000) Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease. Neurology 55:811–815CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Anna Krasnianski
    • 1
    • 4
  • Judith Kaune
    • 1
    • 5
  • Klaus Jung
    • 2
  • Hans A. Kretzschmar
    • 3
  • Inga Zerr
    • 1
  1. 1.Department of Neurology, University Medical CenterNational Reference Center for TSE Surveillance, Georg-August-Universität Göttingen and German Center for Neurodegenerative Diseases (DZNE)GöttingenGermany
  2. 2.Department of Medical StatisticsUniversity Medical Center, Georg-August UniversityGöttingenGermany
  3. 3.Department of NeuropathologyLudwig-Maximilian UniversityMunichGermany
  4. 4.Department of Psychiatry, Psychosomatic Medicine and PsychotherapyGoethe UniversityFrankfurtGermany
  5. 5.Department of NeurologyBremen Mitte HospitalBremenGermany

Personalised recommendations